缩写名/全名 |
HUM VACC IMMUNOTHER
Human Vaccines & Immunotherapeutics |
||||||||||||||||||||||||
ISSN号 | 2164-5515 | ||||||||||||||||||||||||
研究方向 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY-IMMUNOLOGY | ||||||||||||||||||||||||
影响因子 | 2015:2.146, 2016:2.157, 2017:2.229, 2018:2.592, 2019:2.619, | ||||||||||||||||||||||||
出版国家 | UNITED STATES | ||||||||||||||||||||||||
出版周期 | |||||||||||||||||||||||||
年文章数 | 350 | ||||||||||||||||||||||||
出版年份 | 0 | ||||||||||||||||||||||||
是否OA | No | ||||||||||||||||||||||||
审稿周期(仅供参考) | 一般,3-6周 |
||||||||||||||||||||||||
录用比例 | 容易 | ||||||||||||||||||||||||
投稿链接 | |||||||||||||||||||||||||
投稿官网 | http://www.tandfonline.com/loi/khvi20 | ||||||||||||||||||||||||
h-index | 43 | ||||||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2164-5515%5BISSN%5D | ||||||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge. Author: Du R1, Mao Q1, Hu Y2, Lang S3, Sun S1, Li K4, Gao F1, Bian L1, Yang C1, Cui B1, Xu L5, Cheng T5, Liang Z1. Journal: Hum Vaccin Immunother. 2019 Feb 8:1-8. doi: 10.1080/21645515.2019.1565266. [Epub ahead of print] PubMed DOI |
2. | Genotype distribution and prevalence of human papillomavirus among women with cervical cytological abnormalities in Xinjiang, China. Author: Wang J1, Tang D2, Wang J3, Zhang Z3, Chen Y1, Wang K4, Zhang X4, Ma C1. Journal: Hum Vaccin Immunother. 2019 Feb 8:1-8. doi: 10.1080/21645515.2019.1578598. [Epub ahead of print] PubMed DOI |
3. | Outbreak of mumps in a student population with high vaccination coverage in China: time for two-dose vaccination. Author: Qin W1,2,3, Wang Y1, Yang T1, Xu XK1, Meng XM1, Zhao CJ4, Li SY4, Xie SY1, Li KC1, Su H3. Journal: Hum Vaccin Immunother. 2019 Mar 15:1-6. doi: 10.1080/21645515.2019.1581526. [Epub ahead of print] PubMed DOI |
4. | Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing, China. Author: Wang X1,2, An Z1, Huo D2, Jia L2, Li J2, Yang Y2, Liang Z2, Wang Q2, Wang H1. Journal: Hum Vaccin Immunother. 2019;15(5):1183-1190. doi: 10.1080/21645515.2019.1581539. Epub 2019 Mar 20. PubMed DOI |
5. | Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China versus a comparator influenza vaccine: a phase IV randomized study. Author: Hu Y1, Chu K1, Lavis N2, Li X3, Liang B4, Liu S5, Shao M5, Shu JD6, Tabar C7, Samson S8. Journal: Hum Vaccin Immunother. 2019;15(5):1066-1069. doi: 10.1080/21645515.2019.1581541. Epub 2019 Apr 2. PubMed DOI |
6. | PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations. Author: Jiang Y1, Chen M2, Nie H1,3, Yuan Y1. Journal: Hum Vaccin Immunother. 2019;15(5):1111-1122. doi: 10.1080/21645515.2019.1571892. Epub 2019 Mar 19. PubMed DOI |
7. | Response to letter to the editor on analysis. Author: Huang S1, Zhu Z2, Hu Q3. Journal: Hum Vaccin Immunother. 2019 Apr 1:1-2. doi: 10.1080/21645515.2019.1596714. [Epub ahead of print] PubMed DOI |
8. | Low awareness of influenza vaccination among pregnant women and their obstetricians: a population-based survey in Beijing, China. Author: Wang J1, Sun D2, Abudusaimaiti X2, Vermund SH3, Li D4, Hu Y2. Journal: Hum Vaccin Immunother. 2019 Apr 1:1-7. doi: 10.1080/21645515.2019.1596713. [Epub ahead of print] PubMed DOI |
9. | The vaccines-associated Arthus reaction. Author: Peng B1, Wei M2, Zhu FC1, Li JX2. Journal: Hum Vaccin Immunother. 2019 Apr 4:1-9. doi: 10.1080/21645515.2019.1602435. [Epub ahead of print] PubMed DOI |
10. | Economic burden and associated factors of measles patients in Zhejiang Province, China. Author: Deng X1, He H1, Zhou Y1, Xie S1, Fang Y2, Zeng Y2, Yan R1, Tang X1, Fu J1. Journal: Hum Vaccin Immunother. 2019 Apr 22:1-7. doi: 10.1080/21645515.2019.1599673. [Epub ahead of print] PubMed DOI |
|
|